Echtzeit-Aktienkurs NXSTAGE MEDICAL DL-,01
Bid:
Ask:
Echtzeit-Chart der NXSTAGE MEDICAL DL-,01 Aktie
Fundamentaldaten der NXSTAGE MEDICAL DL-,01 Aktie
Income Statement: 10-Year-Summary
| Datum | Umsatz | EBIT | Gewinn | EPS | Dividende | KGV | KUV |
|---|---|---|---|---|---|---|---|
| 2017 [USD] | 393,94 Mio. | -15,47 Mio. | -14,47 Mio. | -0,22 | - | - | - |
| 2016 [USD] | 366,38 Mio. | -6,22 Mio. | -4,77 Mio. | -0,07 | - | - | - |
| 2015 [USD] | 336,12 Mio. | -15,18 Mio. | -15,34 Mio. | -0,24 | - | - | - |
| 2014 [USD] | 301,50 Mio. | -23,06 Mio. | -23,95 Mio. | -0,39 | - | - | - |
| Die Multiples wie die KGVs werden mit der Bilanzwährung und dem Kurs des ausgewählten Börsenplatzes berechnet. Wählen Sie den Börsenplatz mit der Bilanzwährung aus, damit die Multiples korrekt sind. Die fundamentalen Daten werden von Facunda geliefert; Multiples werden mit dem aktuellen Kurs berechnet. |
Profil der NXSTAGE MEDICAL DL-,01 Aktie
NxStage Medical, Inc. (NxStage) is a medical device company that develops, manufactures and markets products for the treatment of kidney failure, fluid overload and related blood treatments and procedures. Its primary product includes the NxStage System One (the System One). NxStage operates in two segments: System One and In-Center. The Company markets the System One to hospitals for treatment of acute kidney failure and fluid overload. In addition to the System One, NxStage sells a line of extracorporeal disposable products for use primarily for in-center dialysis treatments for patients with end-stage renal disease (ESRD). These products, which consist of Medisystems, include hemodialysis blood tubing sets, A.V. fistula needles and apheresis needles. The Company's blood tubing set products include the ReadySet High Performance Blood Tubing set (ReadySet), and the Streamline Airless Blood Tubing set (Streamline).